Selecting a site will automatically redirect you to the site's homepage.
Mehrnaz Sabet, Mokshin Suri and Ruben Trujillo make up the latest cohort of the Cornell Engineering Commercialization Fellowship, a program that helps researchers evaluate their technology through a business lens.
A Cornell-led collaboration succeeded in identifying an elusive mechanism that can trigger degradation in sodium-ion batteries.
Using a computational approach, material scientists at Cornell have found more than 20 new self-assembled crystal structures, which could serve as nanoparticle or colloid design targets for other researchers.
Researchers used thermomechanical nanomolding to create single-crystalline nanowires that enable metastable phases that would otherwise be difficult to achieve.
A novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicated gastric cancer in treated mice, a multi-institutional team of researchers found.
Cornell Engineering faculty and alumni are reimagining design approaches to the materials that make up the world around us to mitigate unintended social and environmental consequences.
An interdisciplinary collaboration used a materials science approach to “fingerprint” calcium mineral deposits that reveal pathological clues to the progression of breast cancer and potentially other diseases.
Materials scientists at Cornell have developed a method for better understanding the complex electrochemical reactions that occur at the interface of water and metal surfaces – an approach that will ultimately lead to better fuel cells and other electrochemical technologies.
Assistant professors Eshan Chattopadhyay, Debanjan Chowdhury, Andrew Musser, Angeline Pendergrass and Andrej Singer have won 2023 Sloan Research Fellowships from the Alfred P. Sloan Foundation.
A new all-dry polymerization technique uses reactive vapors to create thin films with enhanced properties that could lead to improved polymer coatings for microelectronics, advanced batteries and therapeutics.
